Cargando…

A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands

BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanhoe, Anita C., Visser, Maartje, Omlo, Jurriaan J., Watzeels, Anita J. C. M., van den Broek, Ingrid V., Götz, Hannelore M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975518/
https://www.ncbi.nlm.nih.gov/pubmed/29843643
http://dx.doi.org/10.1186/s12879-018-3139-0
_version_ 1783327001637027840
author Nanhoe, Anita C.
Visser, Maartje
Omlo, Jurriaan J.
Watzeels, Anita J. C. M.
van den Broek, Ingrid V.
Götz, Hannelore M.
author_facet Nanhoe, Anita C.
Visser, Maartje
Omlo, Jurriaan J.
Watzeels, Anita J. C. M.
van den Broek, Ingrid V.
Götz, Hannelore M.
author_sort Nanhoe, Anita C.
collection PubMed
description BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study explores the current practice of PN and PT, and benefits of, and barriers and facilitators for PIPT among professionals in sexual health care in the Netherlands. METHODS: A qualitative study was performed among GPs, GP-assistants (GPAs), physicians and nurses working at Sexual Health Clinics (SHC) and key-informants on ethnical diversity using topic lists in focus groups (N = 40) and semi-structured questionnaires in individual interviews (N = 9). Topics included current practices regarding PN and PT, attitude regarding PIPT, and perceived barriers and facilitators for PIPT. Interviews were taped, transcribed verbatim, and coded using ATLAS.ti. A quantitative online questionnaire on the same topics was sent to all physicians and nurses employed at Dutch SHC (complete response rate 26% (84/321)). RESULTS: The qualitative study showed that all professionals support the need for more attention to PN, and that they saw advantages in PIPT. Mentioned barriers included unwilling PN-behaviour, Dutch legislation, several medical considerations and inadequate skills of GPs. Also, concerns about limited knowledge of cultural sensitivity around PN and PT were raised. Mentioned facilitators of PIPT were reliable home based test-kits, phone-contact between professionals and notified partners, more consultation time for GPs or GPAs and additional training. The online questionnaire showed that SHC employees agreed that partners should be treated as soon as possible, but also that they were reluctant towards PIPT without counselling and testing. CONCLUSIONS: Professionals saw advantages in PIPT, but they also identified barriers hampering the potential introduction of PIPT. Improving PN and counselling skills with specific focus on cultural sensitivity is needed. PIPT could be considered for specific partners. PIPT in combination with home based testing and using e-healthcare should be further explored and developed.
format Online
Article
Text
id pubmed-5975518
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59755182018-05-31 A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands Nanhoe, Anita C. Visser, Maartje Omlo, Jurriaan J. Watzeels, Anita J. C. M. van den Broek, Ingrid V. Götz, Hannelore M. BMC Infect Dis Research Article BACKGROUND: Chlamydia prevalence in the Netherlands remains high despite targeted efforts. Effective Partner Notification (PN) and Partner Treatment (PT) can interrupt transmission and prevent re-infections. Patient Initiated Partner Treatment (PIPT) may strengthen chlamydia control. This study explores the current practice of PN and PT, and benefits of, and barriers and facilitators for PIPT among professionals in sexual health care in the Netherlands. METHODS: A qualitative study was performed among GPs, GP-assistants (GPAs), physicians and nurses working at Sexual Health Clinics (SHC) and key-informants on ethnical diversity using topic lists in focus groups (N = 40) and semi-structured questionnaires in individual interviews (N = 9). Topics included current practices regarding PN and PT, attitude regarding PIPT, and perceived barriers and facilitators for PIPT. Interviews were taped, transcribed verbatim, and coded using ATLAS.ti. A quantitative online questionnaire on the same topics was sent to all physicians and nurses employed at Dutch SHC (complete response rate 26% (84/321)). RESULTS: The qualitative study showed that all professionals support the need for more attention to PN, and that they saw advantages in PIPT. Mentioned barriers included unwilling PN-behaviour, Dutch legislation, several medical considerations and inadequate skills of GPs. Also, concerns about limited knowledge of cultural sensitivity around PN and PT were raised. Mentioned facilitators of PIPT were reliable home based test-kits, phone-contact between professionals and notified partners, more consultation time for GPs or GPAs and additional training. The online questionnaire showed that SHC employees agreed that partners should be treated as soon as possible, but also that they were reluctant towards PIPT without counselling and testing. CONCLUSIONS: Professionals saw advantages in PIPT, but they also identified barriers hampering the potential introduction of PIPT. Improving PN and counselling skills with specific focus on cultural sensitivity is needed. PIPT could be considered for specific partners. PIPT in combination with home based testing and using e-healthcare should be further explored and developed. BioMed Central 2018-05-29 /pmc/articles/PMC5975518/ /pubmed/29843643 http://dx.doi.org/10.1186/s12879-018-3139-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nanhoe, Anita C.
Visser, Maartje
Omlo, Jurriaan J.
Watzeels, Anita J. C. M.
van den Broek, Ingrid V.
Götz, Hannelore M.
A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title_full A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title_fullStr A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title_full_unstemmed A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title_short A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands
title_sort pill for the partner via the chlamydia patient? results from a mixed method study among sexual health care providers in the netherlands
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975518/
https://www.ncbi.nlm.nih.gov/pubmed/29843643
http://dx.doi.org/10.1186/s12879-018-3139-0
work_keys_str_mv AT nanhoeanitac apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT vissermaartje apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT omlojurriaanj apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT watzeelsanitajcm apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT vandenbroekingridv apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT gotzhannelorem apillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT nanhoeanitac pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT vissermaartje pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT omlojurriaanj pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT watzeelsanitajcm pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT vandenbroekingridv pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands
AT gotzhannelorem pillforthepartnerviathechlamydiapatientresultsfromamixedmethodstudyamongsexualhealthcareprovidersinthenetherlands